vs
Metallus Inc.（MTUS）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Metallus Inc.的季度营收约是REPLIGEN CORP的1.4倍（$267.3M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -5.3%，领先12.1%），REPLIGEN CORP同比增速更快（13.6% vs 11.1%），REPLIGEN CORP自由现金流更多（$17.6M vs $-37.2M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -8.8%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
MTUS vs RGEN — 直观对比
营收规模更大
MTUS
是对方的1.4倍
$197.9M
营收增速更快
RGEN
高出2.5%
11.1%
净利率更高
RGEN
高出12.1%
-5.3%
自由现金流更多
RGEN
多$54.8M
$-37.2M
两年增速更快
RGEN
近两年复合增速
-8.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $197.9M |
| 净利润 | $-14.3M | $13.3M |
| 毛利率 | 2.2% | 52.5% |
| 营业利润率 | -7.7% | 9.0% |
| 净利率 | -5.3% | 6.7% |
| 营收同比 | 11.1% | 13.6% |
| 净利润同比 | 33.2% | 143.9% |
| 每股收益（稀释后） | $-0.34 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTUSRGEN
| Q4 25 | $267.3M | $197.9M | ||
| Q3 25 | $305.9M | $188.8M | ||
| Q2 25 | $304.6M | $182.4M | ||
| Q1 25 | $280.5M | $169.2M | ||
| Q4 24 | $240.5M | $174.1M | ||
| Q3 24 | $227.2M | $154.9M | ||
| Q2 24 | $294.7M | $154.1M | ||
| Q1 24 | $321.6M | $151.3M |
净利润MTUSRGEN
| Q4 25 | $-14.3M | $13.3M | ||
| Q3 25 | $8.1M | $14.9M | ||
| Q2 25 | $3.7M | $14.9M | ||
| Q1 25 | $1.3M | $5.8M | ||
| Q4 24 | $-21.4M | $-30.3M | ||
| Q3 24 | $-5.9M | $-654.0K | ||
| Q2 24 | $4.6M | $3.3M | ||
| Q1 24 | $24.0M | $2.1M |
毛利率MTUSRGEN
| Q4 25 | 2.2% | 52.5% | ||
| Q3 25 | 11.4% | 53.2% | ||
| Q2 25 | 10.6% | 50.0% | ||
| Q1 25 | 7.8% | 53.6% | ||
| Q4 24 | 4.5% | 26.1% | ||
| Q3 24 | 5.3% | 50.0% | ||
| Q2 24 | 8.2% | 49.8% | ||
| Q1 24 | 15.7% | 49.5% |
营业利润率MTUSRGEN
| Q4 25 | -7.7% | 9.0% | ||
| Q3 25 | 3.6% | 8.9% | ||
| Q2 25 | 2.8% | 7.6% | ||
| Q1 25 | 1.0% | 3.9% | ||
| Q4 24 | -10.1% | -17.7% | ||
| Q3 24 | -3.1% | -5.1% | ||
| Q2 24 | 2.1% | 1.0% | ||
| Q1 24 | 9.3% | 1.3% |
净利率MTUSRGEN
| Q4 25 | -5.3% | 6.7% | ||
| Q3 25 | 2.6% | 7.9% | ||
| Q2 25 | 1.2% | 8.2% | ||
| Q1 25 | 0.5% | 3.4% | ||
| Q4 24 | -8.9% | -17.4% | ||
| Q3 24 | -2.6% | -0.4% | ||
| Q2 24 | 1.6% | 2.2% | ||
| Q1 24 | 7.5% | 1.4% |
每股收益（稀释后）MTUSRGEN
| Q4 25 | $-0.34 | $0.24 | ||
| Q3 25 | $0.19 | $0.26 | ||
| Q2 25 | $0.09 | $0.26 | ||
| Q1 25 | $0.03 | $0.10 | ||
| Q4 24 | $-0.46 | $-0.55 | ||
| Q3 24 | $-0.13 | $-0.01 | ||
| Q2 24 | $0.10 | $0.06 | ||
| Q1 24 | $0.52 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.7M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $686.0M | $2.1B |
| 总资产 | $1.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资MTUSRGEN
| Q4 25 | $156.7M | $767.6M | ||
| Q3 25 | $191.5M | $748.7M | ||
| Q2 25 | $190.8M | $708.9M | ||
| Q1 25 | $180.3M | $697.2M | ||
| Q4 24 | $240.7M | $757.4M | ||
| Q3 24 | $254.6M | $784.0M | ||
| Q2 24 | $272.8M | $809.1M | ||
| Q1 24 | $278.1M | $780.6M |
总债务MTUSRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | $0 | $537.9M | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $5.4M | $525.6M | ||
| Q3 24 | $13.2M | — | ||
| Q2 24 | $13.2M | — | ||
| Q1 24 | $13.2M | — |
股东权益MTUSRGEN
| Q4 25 | $686.0M | $2.1B | ||
| Q3 25 | $697.7M | $2.1B | ||
| Q2 25 | $690.0M | $2.1B | ||
| Q1 25 | $686.1M | $2.0B | ||
| Q4 24 | $690.5M | $2.0B | ||
| Q3 24 | $712.7M | $2.0B | ||
| Q2 24 | $736.3M | $2.0B | ||
| Q1 24 | $739.3M | $2.0B |
总资产MTUSRGEN
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.2B | $2.9B | ||
| Q2 25 | $1.1B | $2.9B | ||
| Q1 25 | $1.1B | $2.9B | ||
| Q4 24 | $1.1B | $2.8B | ||
| Q3 24 | $1.1B | $2.8B | ||
| Q2 24 | $1.1B | $2.9B | ||
| Q1 24 | $1.2B | $2.8B |
负债/权益比MTUSRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | 0.00× | 0.26× | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | 0.27× | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-37.2M | $17.6M |
| 自由现金流率自由现金流/营收 | -13.9% | 8.9% |
| 资本支出强度资本支出/营收 | 13.2% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-93.0M | $93.9M |
8季度趋势，按日历期对齐
经营现金流MTUSRGEN
| Q4 25 | $-1.9M | $25.7M | ||
| Q3 25 | $22.0M | $48.1M | ||
| Q2 25 | $34.8M | $28.6M | ||
| Q1 25 | $-38.9M | $15.0M | ||
| Q4 24 | $13.9M | $39.2M | ||
| Q3 24 | $-15.3M | $49.3M | ||
| Q2 24 | $8.3M | $42.2M | ||
| Q1 24 | $33.4M | $44.7M |
自由现金流MTUSRGEN
| Q4 25 | $-37.2M | $17.6M | ||
| Q3 25 | $-6.4M | $43.4M | ||
| Q2 25 | $17.0M | $21.5M | ||
| Q1 25 | $-66.4M | $11.4M | ||
| Q4 24 | $-1.3M | $33.6M | ||
| Q3 24 | $-32.9M | $42.3M | ||
| Q2 24 | $-5.8M | $37.4M | ||
| Q1 24 | $16.0M | $36.4M |
自由现金流率MTUSRGEN
| Q4 25 | -13.9% | 8.9% | ||
| Q3 25 | -2.1% | 23.0% | ||
| Q2 25 | 5.6% | 11.8% | ||
| Q1 25 | -23.7% | 6.8% | ||
| Q4 24 | -0.5% | 19.3% | ||
| Q3 24 | -14.5% | 27.3% | ||
| Q2 24 | -2.0% | 24.3% | ||
| Q1 24 | 5.0% | 24.0% |
资本支出强度MTUSRGEN
| Q4 25 | 13.2% | 4.1% | ||
| Q3 25 | 9.3% | 2.5% | ||
| Q2 25 | 5.8% | 3.9% | ||
| Q1 25 | 9.8% | 2.1% | ||
| Q4 24 | 6.3% | 3.2% | ||
| Q3 24 | 7.7% | 4.5% | ||
| Q2 24 | 4.8% | 3.1% | ||
| Q1 24 | 5.4% | 5.5% |
现金转化率MTUSRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 2.72× | 3.23× | ||
| Q2 25 | 9.41× | 1.92× | ||
| Q1 25 | -29.92× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.80× | 12.70× | ||
| Q1 24 | 1.39× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTUS
| Industrial Market Sector | $95.3M | 36% |
| Manufactured Components | $67.8M | 25% |
| Aerospace And Defense | $39.6M | 15% |
| Seamless Mechanical Tubing | $31.3M | 12% |
| Energy Market Sector | $18.3M | 7% |
| Other | $11.3M | 4% |
| Other Market Sector | $3.7M | 1% |
RGEN
暂无分部数据
